Back to all Portfolio news
December 18, 2013

EndoChoice To Present at J.P. Morgan Healthcare Conference

EndoChoice announced today it will present at the 32nd annual J.P. Morgan Healthcare Conference.  Mark Gilreath, Founder and CEO at EndoChoice will review the company’s future prospects while summarizing five consecutive years of quarterly revenue growth.

Mr. Gilreath will be presenting on Wednesday, January 15, 2014 at 930am in the Elizabethan C meeting room at the Westin St. Francis Hotel in San Francisco.  The conference will take place Monday, January 13, through Thursday, January 16, 2014.

The annual J.P. Morgan Healthcare Conference is the largest healthcare investment symposium in the industry. The expected attendance includes more than 300 companies, both public and private, to deliver presentations to more than 3,000 investors.